Pharmaron Beijing Market Cap

Pharmaron Beijing has a market cap or net worth of 38.21 billion as of June 20, 2025. Its market cap has increased by 10.59% in one year.

Market Cap

38.21B

Enterprise Value

42.08B

Revenue

12.70B

Ranking

n/a

PE Ratio

21.88

Stock Price

23.09

Market Cap Chart

Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 38.21B, an increase of 427.81%. That is a compound annual growth rate of 29.70%.

Market Cap History

Date	Market Cap	% Change
Jun 20, 2025	38.21B	-8.69%
Dec 31, 2024	41.85B	-11.66%
Dec 29, 2023	47.37B	-38.44%
Dec 30, 2022	76.95B	-27.67%
Dec 31, 2021	106.40B	12.84%
Dec 31, 2020	94.29B	140.25%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	343.26B
Shenzhen Mindray Bio-Medical Electronics	274.85B
WuXi AppTec	187.01B
Zhangzhou Pientzehuang Pharmaceutical.,	120.66B
Sichuan Biokin Pharmaceutical	117.45B
Aier Eye Hospital Group	110.25B
Shanghai United Imaging Healthcare	105.34B
Yunnan Baiyao Group Co.,Ltd	98.19B

Market Cap Rankings